Tiburon, CA, United States of America

Lynn E Spitler


Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 172(Granted Patents)


Company Filing History:


Years Active: 1976-2000

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Lynn E Spitler: Innovator in Immunogenic Compositions

Introduction

Lynn E Spitler is a prominent inventor based in Tiburon, California. She has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. With a total of six patents to her name, Spitler's work has the potential to impact the future of drug delivery systems and cancer treatment.

Latest Patents

Among her latest patents, one notable invention is an immunogenic composition that comprises a stable oil-in-water emulsion. This composition features a continuous water phase and a discontinuous oil phase, utilizing smectic mesophase vesicles as the sole stabilizing agent. This formulation is designed to be stable and useful as an adjuvant in vaccines or drug delivery systems. Another significant patent involves a method to elicit an antitumor response specifically targeting human prostate tumors. This vaccine is capable of generating an immune response against prostate-specific antigens, utilizing human PSA as the active ingredient.

Career Highlights

Throughout her career, Lynn E Spitler has worked with notable companies such as Xoma Corporation and Jenner Technologies. Her experience in these organizations has allowed her to refine her expertise in immunology and vaccine development.

Collaborations

Spitler has collaborated with esteemed colleagues, including Patrick J Scannon and Howard M Lee. These partnerships have contributed to her innovative research and the advancement of her patented technologies.

Conclusion

Lynn E Spitler's contributions to immunogenic compositions and vaccine development highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in medical science and cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…